Skip to content

Clinical trials

Carcinoma, Non-Small-Cell Lung trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Country / region: Russia Clear all

201 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20023
20042
20055
20069
20074
200810
20097
201010
201113
20125
201310
20145
201519
20165
201712
201817
201918
202023
202111
20222
20233
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed122
Active, not recruiting39
Terminated29
Unknown status5
Recruiting3
Withdrawn2
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca26
Hoffmann-La Roche19
Pfizer13
Novartis Pharmaceuticals12
Bristol-Myers Squibb9
Eli Lilly and Company9
GlaxoSmithKline9
Merck Sharp & Dohme LLC9
Boehringer Ingelheim6
EMD Serono Research & Development Institute, Inc.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung201
Lung Neoplasms33
Neoplasms16
Neoplasm Metastasis13
Carcinoma7
Adenocarcinoma of Lung6
Cachexia5
Melanoma5
Breast Neoplasms4
Carcinoma, Squamous Cell4

Trials

Showing 1 to 25 of 201. Each trial links to its page on Pharma Observatory.

101 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.